Xenon Pharmaceuticals Inc... (XENE)
NASDAQ: XENE
· Real-Time Price · USD
38.23
0.27 (0.71%)
At close: Aug 15, 2025, 3:59 PM
38.23
0.00%
After-hours: Aug 15, 2025, 04:10 PM EDT
0.71% (1D)
| Bid | 31 |
| Market Cap | 2.95B |
| Revenue (ttm) | 7.5M |
| Net Income (ttm) | -251.45M |
| EPS (ttm) | -3.55 |
| PE Ratio (ttm) | -10.77 |
| Forward PE | -7.61 |
| Analyst | Buy |
| Ask | 39 |
| Volume | 609,416 |
| Avg. Volume (20D) | 1,223,023.2 |
| Open | 38.14 |
| Previous Close | 37.96 |
| Day's Range | 37.32 - 38.50 |
| 52-Week Range | 26.74 - 46.00 |
| Beta | 1.17 |
About XENE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol XENE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for XENE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
-17.43%
Xenon Pharmaceuticals shares are trading lower. Th...
Unlock content with
Pro Subscription
3 months ago
+2.37%
Xenon Pharmaceuticals shares are trading lower. The company reported Q1 financial results.
3 days ago · seekingalpha.com
Xenon Pharmaceuticals Inc. (XENE) Q2 2025 Earnings Call TranscriptXenon Pharmaceuticals Inc. (NASDAQ:XENE ) Q2 2025 Earnings Conference Call August 11, 2025 4:30 PM ET Company Participants Chad Fugere - Vice President, Investor Relations Christopher John Kenney - Ch...
3 months ago · proactiveinvestors.co.uk
Polarean's Xenon MRI technology to feature in over 30 studies at American Thoracic Society eventsPolarean Imaging PLC (AIM:POLX, OTC:PLLWF), the AIM-listed medical imaging company, will have its Xenon-based magnetic resonance imaging (MRI) technology showcased in more than 30 clinical studies at ...